Literature DB >> 29266392

Short pulse width in subthalamic stimulation in Parkinson's disease: a randomized, double-blind study.

Walid Bouthour1,2, Jennifer Wegrzyk1, Shahan Momjian3, Julie Péron1, Vanessa Fleury1, Emilie Tomkova Chaoui1, Judit Horvath1, Colette Boëx1, Christian Lüscher1,2, Pierre R Burkhard1, Paul Krack1, André Zacharia1,4.   

Abstract

BACKGROUND: We investigated the acute effect of short pulse widths on the therapeutic window in subthalamic nucleus deep brain stimulation in Parkinson's disease.
METHODS: We assessed 10 PD patients with STN-DBS at a 60-µs pulse width. We randomly and double-blindedly applied 10- to 50-µs pulse widths. The principal outcome was the therapeutic window (difference between the amplitude thresholds for visible muscle contraction and for best rigidity control). The secondary outcome was the charge per pulse (which reflects the efficiency of the stimulation) needed to control rigidity. Two-way analysis of variance and pairwise t tests were applied.
RESULTS: The therapeutic window widened when the pulse width shortened (r = -0.45; P < 0.001), and charge per pulse was reduced (P < 0.05).
CONCLUSIONS: This randomized, double-blind study showed that shorter pulse widths widen the therapeutic window of STN-DBS in PD without increasing the electrical charge required to obtain the same acute clinical benefit.
© 2017 International Parkinson and Movement Disorder Society. © 2017 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; deep brain stimulation; pulse width; rigidity; subthalamic nucleus

Mesh:

Year:  2017        PMID: 29266392     DOI: 10.1002/mds.27265

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  7 in total

1.  Neural selectivity, efficiency, and dose equivalence in deep brain stimulation through pulse width tuning and segmented electrodes.

Authors:  Collin J Anderson; Daria Nesterovich Anderson; Stefan M Pulst; Christopher R Butson; Alan D Dorval
Journal:  Brain Stimul       Date:  2020-04-09       Impact factor: 8.955

Review 2.  Emerging technologies for improved deep brain stimulation.

Authors:  Hayriye Cagnan; Timothy Denison; Cameron McIntyre; Peter Brown
Journal:  Nat Biotechnol       Date:  2019-09-02       Impact factor: 54.908

3.  Modeling of Electric Fields in Individual Imaging Atlas for Capsular Threshold Prediction of Deep Brain Stimulation in Parkinson's Disease: A Pilot Study.

Authors:  Matthieu Béreau; Astrid Kibleur; Walid Bouthour; Emilie Tomkova Chaoui; Nicholas Maling; T A Khoa Nguyen; Shahan Momjian; Maria Isabel Vargas Gomez; André Zacharia; Julien F Bally; Vanessa Fleury; Laurent Tatu; Pierre R Burkhard; Paul Krack
Journal:  Front Neurol       Date:  2020-07-02       Impact factor: 4.003

4.  Surgical Strategy for Directional Deep Brain Stimulation.

Authors:  Hiroshi Masuda; Hiroshi Shirozu; Yosuke Ito; Masafumi Fukuda; Yukihiko Fujii
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-10-29       Impact factor: 1.742

Review 5.  Past, Present, and Future of Deep Brain Stimulation: Hardware, Software, Imaging, Physiology and Novel Approaches.

Authors:  Jessica Frey; Jackson Cagle; Kara A Johnson; Joshua K Wong; Justin D Hilliard; Christopher R Butson; Michael S Okun; Coralie de Hemptinne
Journal:  Front Neurol       Date:  2022-03-09       Impact factor: 4.003

6.  Short pulse and directional thalamic deep brain stimulation have differential effects in parkinsonian and essential tremor.

Authors:  Chi-Un Choe; Monika Pötter-Nerger; Ute Hidding; Miriam Schaper; Alessandro Gulberti; Carsten Buhmann; Christian Gerloff; Christian K E Moll; Wolfgang Hamel
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

7.  A Randomized, Double-Blinded Crossover Trial of Short Versus Conventional Pulse Width Subthalamic Deep Brain Stimulation in Parkinson's Disease.

Authors:  Jan Niklas Petry-Schmelzer; Lisa M Schwarz; Hannah Jergas; Paul Reker; Julia K Steffen; Haidar S Dafsari; Juan Carlos Baldermann; Gereon R Fink; Veerle Visser-Vandewalle; Till A Dembek; Michael T Barbe
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.